NextCure, Inc. (NXTC) Net income 2018–2025
NextCure, Inc. (NXTC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$55.8MFY2025 · since FY2018: -$22.8M → -$55.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$55.8M | -0.3% |
| FY2024 | -$55.7M | +11.3% |
| FY2023 | -$62.7M | +16.1% |
| FY2022 | -$74.7M | -7.7% |
| FY2021 | -$69.4M | -89.6% |
| FY2020 | -$36.6M | -8.5% |
| FY2019 | -$33.7M | -48.0% |
| FY2018 | -$22.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice